Back
Krystal Biotech, Inc. Stock Predictions
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
70
KRYS
Krystal Biotech, Inc.
Last Price:
$261.38
Seasonality Move:
12.7%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atKrystal Biotech, Inc. Stock Forecast
-
Over the next 52 weeks, Krystal Biotech, Inc. has on average historically risen by 55.3% based on the past 8 years of stock performance.
-
Krystal Biotech, Inc. has risen higher in 8 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Krystal Biotech, Inc. Stock Undervalued?The current Krystal Biotech, Inc. [KRYS] share price is $261.41. The Score for KRYS is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
KRYS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Krystal Biotech, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Krystal Biotech, Inc. has on average historically risen by 55.3% based on the past 8 years of stock performance.
Krystal Biotech, Inc. Stock Rating
Buy
70
Krystal Biotech, Inc. (KRYS)
is a Buy
Is Krystal Biotech, Inc. overpriced?
-
Krystal Biotech, Inc. has risen higher in 8 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Krystal Biotech, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
krystalbio.com
52-Week Data
52-Week High:
267.48
52-Week Low:
122.80
Prediction Charts
Market Cap:
7.6B
Price in USD:
261.41
Volume:
349.9K
Beta:
0.83
Technical Analysis
SMA50:
223.51
SMA100:
194.67
SMA200:
171.67
52-Wk Change:
66.85%
Stock Predictions
-
Is Krystal Biotech, Inc. stock public?Yes, Krystal Biotech, Inc. is a publicly traded company.
-
What is the Krystal Biotech, Inc. stock quote today?The Krystal Biotech, Inc. stock price is 261.41 USD today.
-
How to buy Krystal Biotech, Inc. stock online?You can buy Krystal Biotech, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-18 | 238.81 | 233.37 | 239.52 | 231.69 |
| Dec-19 | 233.25 | 240.80 | 245.30 | 231.91 |
| Dec-22 | 241.43 | 249.61 | 249.78 | 241.43 |
| Dec-23 | 249.27 | 253.36 | 255.00 | 248.90 |
| Dec-24 | 253.67 | 251.29 | 253.90 | 249.73 |
| Dec-26 | 251.63 | 252.17 | 252.55 | 249.00 |
| Dec-29 | 251.39 | 253.68 | 265.92 | 248.48 |
| Dec-30 | 253.00 | 247.88 | 256.00 | 246.90 |
| Dec-31 | 247.69 | 246.54 | 250.09 | 245.89 |
| Jan-5 | 246.55 | 244.71 | 247.00 | 235.61 |
| Jan-6 | 250.44 | 249.39 | 257.95 | 246.24 |
| Jan-7 | 250.45 | 246.37 | 254.50 | 245.68 |
| Jan-8 | 249.51 | 248.91 | 255.07 | 245.99 |
| Jan-9 | 254.51 | 261.41 | 267.48 | 252.92 |
Krystal Biotech, Inc. Earnings
Krystal Biotech, Inc. Earnings Report: Per Share Krystal Biotech, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Krystal Biotech, Inc. Forecast Revenue Growth
Krystal Biotech, Inc. Stock Analysis: Historical quarterly revenues per share for Krystal Biotech, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.60 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and an increase next year of $4.37 per share.
* Krystal Biotech, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.